Localization of ligand-binding sites on human C1q globular head region using recombinant globular head fragments and single-chain antibodies

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1652, Issue 1, 2003, Pages 64-74

  Kojouharova, Mihaela S ^a   Tsacheva, Ivanka G ^a   Tchorbadjieva, Magdalena I ^a   Reid, Kenneth B M ^b   Kishore, Uday ^b,c  

^a UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

C1q; Complement; Recombinant module; Single chain antibody; Therapeutic

Indexed keywords

AGGLUTININ; COLLAGEN; COMPLEMENT COMPONENT C1Q; GLYCOPROTEIN; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; LIGAND; PORIN; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN G; OUTER MEMBRANE PROTEIN; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; KLEBSIELLA PNEUMONIAE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SALIVA; ANTIBODY SPECIFICITY; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SALIVARY GLAND;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; KLEBSIELLA; KLEBSIELLA PNEUMONIAE;

AGGLUTININS; ANTIBODY SPECIFICITY; BACTERIAL OUTER MEMBRANE PROTEINS; BINDING SITES; COMPLEMENT C1Q; HIV ENVELOPE PROTEIN GP41; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KLEBSIELLA PNEUMONIAE; LIGANDS; PEPTIDE FRAGMENTS; PORINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SALIVARY GLANDS;

EID: 1242318747     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2003.08.003     Document Type: Article

References (41)

1. Sellar G.C., Blake D.J.K., Reid K.B.M. Characterization and organization of the genes encoding the A, B and C chains of human complement subcomponent C1q. The complete derived amino acid sequence of human C1q. Biochem. J. 274:1991;481-490.
2. Reid K.B.M., Porter R.R. Subunit composition and structure of subcomponent C1q of the first component of human complement. Biochem. J. 155:1976;19-23.
3. Kishore U., Reid K.B.M. Modular organization of proteins containing C1q-like globular domain. Immunopharmacology. 42:1999;15-21.
4. Kishore U., Reid K.B.M. C1q: structure, function and receptors. Immunopharmacology. 49:2000;159-163.
5. Kishore U., Kojouharova M.S., Reid K.B.M. Recent progress in the understanding of structure-function relationships of globular head regions of C1q. Immunobiology. 205:2002;355-364.
6. Kishore U., Gupta S.K., Perdikoulis M.V., Kojouharova M.S., Urban B.C., Reid K.B.M. Modular organization of the carboxy-terminal, globular head region of human C1q A, B and C chains. J. Immunol. 171:2003;812-820.
7. Stemmer F., Loos M. Purification and characterization of human, guinea pig and mouse C1q. J. Immunol. Methods. 74:1984;9-16.
8. Alberty S., Marques G., Camprubi M., Smerino J., Tomas M., Vivanco F., Benedi V.J. C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins. Infect. Immun. 61:1993;852-860.
9. Boackle R.J., Connor M.H., Vesely J. High molecular weight non-immunoglobulin salivary agglutinins bind C1q globular heads and have the potential to activate the first complement component. Mol. Immunol. 30:1993;309-319.
10. Prakobphol A., Xu F., Hoang V.M., Larsson T., Bergstrom J., Johansson I., Frangsmyr L., Holmskov U., Leffler H., Nilsson C., Boren T., Wright J.R., Stromberg N., Fisher S.J. Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340. J. Biol. Chem. 275:2000;39860-39866.
11. Kishore U., Leigh L.E.A., Eggleton P., Strong P., Perdikoulis M.V., Willis A.C., Reid K.B.M. Functional characterization of a recombinant form of the carboxy-terminal, globular head region of the B-chain of human serum protein, C1q. Biochem. J. 333:1998;27-32.
12. Kishore U., Strong P., Perdikoulis M.V., Reid K.B.M. A recombinant homotrimer, composed of the α-helical neck region of human surfactant protein D and C1q B chain globular domain, is an inhibitor of the classical complement pathway. J. Immunol. 166:2001;559-565.
13. Kontermann R.E., Wing M.G., Winter G. Complement recruitment using bispecific diabodies. Nat. Biotechnol. 15:1997;629-631.
14. Griffiths A.D., Williams S.C., Harley O., Tomlinson I.M., Waterhouse P., Crosby W.L., Kontermann R.E., Jones P.T., Low N.M., Allison T.J., Prospero T.D., Hoogenboom H.R., Nissim A., Cox J.P.L., Harrison J.L., Zaccolo M., Gherardi E., Winter G. Isolation of high affinity human antibodies directly from large synthetic libraries. EMBO J. 12:1994;725-753.
15. Tsacheva I., Argirova T., Panchev I., Kojouharova M.S. Characterization of C1q specific single chain antibodies, generated by phage display technology. Biotechnol. Biotech. Equip. 2:2002;48-56.
16. Holliger P., Wing M., Pound G.D., Bohlen H., Winter G. Re-targeting serum immunoglobulin with bispecific antibodies. Nat. Biotechnol. 15:1997;632-636.
17. Thielens M.N., Bally I.M., Ebenbichler C.F., Dierich M.P., Arlaud G.J. Further characterization of the interaction between the C1q subcomponent of human C1 and the transmembrane envelope glycoprotein gp41 of HIV-1. J. Immunol. 151:1993;6583-6592.
18. Shapiro L., Scherer P.E. The crystal structure of a C1q family protein suggests an evolutionary link to tumor necrosis factor. Curr. Biol. 8:1998;335-338.
19. Jones E.Y., Stuart D.I., Walker N.P. Structure of tumor necrosis factor. Nature. 338:1989;225-228.
20. Duncan A.R., Winter G. The binding site for C1q on IgG. Nature. 332:1988;738-740.
21. Perkins S.J., Nealis A.S., Sutton B.J., Feinstein A. Solution structure of human and mouse immunoglobulin M by synchrotron X-ray scattering and molecular modeling: a possible mechanism for complement activation. J. Mol. Biol. 221:1991;1345-1366.
22. Marques G., Anton L.C., Barrio E., Sanchez A., Ruiz S., Gavilanes F., Vivanco F. Arginine residues of the globular regions of human C1q involved in the interaction with immunoglobulin G. J. Biol. Chem. 268:1993;10393-10402.
23. Caffrey M. Model for the structure of the HIV gp41 ectodomain: insight into the intermolecular interactions of the gp41 loop. Biochim. Biophys. Acta. 1536:2001;116-122.
24. Quinkal I., Hernandez J.F., Chevallier S., Arlaud G.J., Vernet T. Mapping of the interaction between the immunodominant loop of the ectodomain of HIV-1 gp41 and human complement protein C1q. Eur. J. Biochem. 265:1999;656-663.
25. Sagara Y., Inoue Y., Shiraki H., Jinno A., Hoshino H., Maeda Y. Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides. J. Virol. 170:1996;1564-1569.
26. Gasque P., Dean Y.D., McGreal E.P., Van Beek J., Morgan B.P. Complement components of the innate immune system in health and disease in the central nervous system. Immunopharmacology. 49:2000;171-186.
27. Webster S., Glabe C., Rogers J. Multivalent binding of complement protein C1q to the amyloid β-peptide (Aβ) promotes the nucleation phase of Aβ aggregation. Biochem. Biophys. Res. Commun. 217:1995;869-875.
28. Tacnet-Delorme P., Chevallier S., Arlaud G.J. β-Amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for Aβ on the C1q globular regions. J. Immunol. 167:2001;6374-6381.
29. Navratil J.S., Watkins S.C., Wisnieski J.J., Ahearn J.M. The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J. Immunol. 166:2001;3231-3239.
30. Nauta A.J., Bottazzi B., Mantovani A., Salvatori G., Kishore U., Schwaeble W.J., Gingras A.R., Tzima S., Vivanco F., Egido J., Tijsma O., Hack E.C., Daha M.R., Roos A. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur. J. Immunol. 33:2003;465-473.
31. Alberty S., Marques G., Hernandes-Alles S., Rubires X., Tomas J.M., Vivanco F., Benedi V.J. Interaction between complement subcomponent C1q and Klebsiella pneumoniae porin OmpK36. Infect. Immun. 64:1996;4719-4725.
32. Holmskov U., Lawson P., Teisner B., Tornoe I., Willis A.C., Morgan C., Koch C., Reid K.B.M. Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein D-binding molecule. J. Biol. Chem. 272:1997;13743-13749.
33. Tino M.J., Wright J.R. Glycoprotein-340 binds surfactant protein A (SP-A) and stimulates alveolar macrophage migration in an SP-A independent manner. Am. J. Respir. Cell Mol. Biol. 20:1999;759-768.
34. Holmskov U., Mollenhauer J., Madsen J., Vitved L., Gronlund J., Tornoe I., Kleim A., Reid K.B.M., Poustka A., Skjodt K. Cloning of gp340, a putative opsonin receptor for lung surfactant protein D. Proc. Natl. Acad. Sci. U. S. A. 96:1999;10794-10799.
35. Kang W., Reid K.B.M. DMBT1, a regulator of mucosal homeostasis through the linking of mucosal defense and regeneration? FEBS Lett. 540:2003;21-25.
36. Hartshorn, K.L., White, M.R., Mogues, T., Ligtenberg, T., Crouch, E.C., Holmskov, U., Lung and salivary scavenger receptor glycoprotein-340 (gp-340) contribute to the host defense against Influenza A viruses. Am. J. Physiol., Lung Cell. Mol. Physiol., in press.
37. Kojouharova M.S., Panchev I.D., Tchorbadjieva M.I., Reid K.B.M., Hoppe H.J. Differential binding of IgG and of a HIV gp41 peptide by the B chain and A chain globular head sequences of C1q, respectively. J. Immunol. 161:1998;4325-4331.
38. Idusogie E.E., Presta L.G., Gazzano-Santoro H., Totpal K., Wong P.Y., Ultsch M., Meng Y.G., Mulkerrin G. Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc. J. Immunol. 164:2000;4178-4184.
39. Stoiber H., Thielens N.M., Ebenbichler C., Arlaud G.J., Dierich M.P. The envelope glycoprotein of HIV-1 gp120 and human complement protein C1q bind to the same peptides derived from three different regions of gp41, transmembrane glycoprotein of HIV-1, and share antigenic homology. Eur. J. Immunol. 24:1994;294-300.
40. Roos A., Nauta A.J., Broers D., Faber-Krol M.C., Trouw L.A., Drijfhout J.W., Daha M.R. Specific inhibition of the classical complement pathway by C1q-binding peptides. J. Immunol. 167:2001;7052-7059.
41. Roos A., Ramwadhdoebe T.H., Nauta A.J., Hack C.E., Daha M.R. Therapeutic inhibition of the early phase of complement activation. Immunobiology. 205:2002;595-609.